Brazil

BMI View: Collaborations between public and private hospitals, regulatory agencies, pharmaceutical companies, research centres, academia and government will become increasingly important... 2010-08-18

Revenue for fiscal 2009 was BRL2.0bn (US$1.0bn), representing an almost six-fold increase in sales over a five-year period. Additionally, net income has grown almost ten-fold since... 2010-08-16

BMI View: With the creation of free trade agreements (FTAs) giving increased access to international markets and the strong growth of domestic demand, South American countries in the... 2010-08-13

During the first half of 2010, only 84 marketing authorisation applications for generic drugs were registered in Brazil, according to the Brazilian Association of Industries of Generic... 2010-07-29

General Electric (GE) is to invest US$150mn over the next 18 months on a research and development (R&D) centre in Brazil. The US multinational is currently negotiating with several... 2010-07-19

BMI View: While the number of HIV infections in the major pharmaceutical markets represents a relatively small proportion of the globally infected population, emerging markets will... 2010-07-15

Private healthcare providers are to reimburse the Brazilian public healthcare system - Sistema Único de Saúde (SUS) - in the same way that private hospitals are currently reimbursed... 2010-07-13